Evernow is a telehealth company led by CEO Alicia Jackson, PhD, that uses technology to match women with tailored prescription treatments and expert clinicians for ongoing virtual support. Its platform aims to address both near-term and long-term symptoms stemming from hormonal changes in perimenopause and menopause through a user-friendly interface. The company has studied more than 100,000 women experiencing perimenopause and menopause symptoms. Since founding in 2019 and operating from San Francisco, Evernow has been building clinical and research capabilities; recent hires include Chief Medical Officer Leah Millheiser, MD, NCMP, psychiatrist Allie Sharma, MD, MSc, and ovarian biology expert Jennifer Garrison, PhD. Evernow intends to use recent funding to expand the team, build its member community, and leverage data and research to drive product development.

Total raised

$29M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2022